How does l & east. eur make money?

l & east. eur generates n/a in annual revenue (annual revenue).

What is CEE's XVARY composite score?

l & east. eur (CEE) has an XVARY composite score of 35/100, rated weak. This combines growth, value, risk, and momentum factors.

CEE — l & east. eur stock analysis

Start here if you're new

what it is

This is a closed-end fund that buys stocks in Central and Eastern Europe, with at least 80% in regional equities.

how it gets paid

Last year L & East. Eur made n/a in revenue. financials holdings was the main engine at 36% of net assets, or 36% of sales.

what just happened

There is no quarterly earnings figure provided in the source set, so the only verified profit number is the $0.65 forward EPS estimate.

At a glance

40.4x trailing p/e — you're paying up for this one

2.2% dividend yield — cash in your pocket every quarter

$0.65 fy2029 eps est

1.25 beta

~$125M market cap

xvary composite: 35/100 — weak

What they do

This is a closed-end fund that buys stocks in Central and Eastern Europe, with at least 80% in regional equities.

The edge is concentration with rules. The fund must keep at least 80% of assets in Central and Eastern Europe equities, and nearly two-thirds of holdings were in Poland as of December 31, 2025. If you want direct exposure to that market without picking banks, retailers, and energy names yourself, this wrapper does the job.

consumer small-cap closed-end-fund poland-exposure emerging-markets

How they make money

n/a annual revenue

financials holdings

36% of net assets

consumer holdings

22% of net assets

industrials holdings

11% of net assets

energy holdings

10% of net assets

telecom services holdings

9% of net assets

materials, utilities, and other

12% of net assets

The products that matter

defensive portfolio exposure

consumer staples

~12% of portfolio

At roughly 12%, this is the largest visible sector bucket. It gives you some ballast, but not enough to define the whole fund.

top sector

cyclical portfolio exposure

industrials

~11% of portfolio

At about 11%, industrials keep the fund tied to regional economic activity. If the area slows, this slice feels it.

11% mix

commodity-linked exposure

energy

~10% of portfolio

At around 10%, energy adds upside when regional commodity names work. It also adds another reason the ride gets louder.

10% mix

Key numbers

40.4x

trailing p/e

Price-to-earnings ratio → what you pay for each dollar of profit → 40.4x is rich for a $125 million country-heavy fund.

2.2%

dividend yield

Dividend yield → annual cash payout as a share of price → you get some income, but not enough to mask a bad downturn.

1.25

beta

Beta → how jumpy the shares are versus the market → this has moved about 25% more than the market historically.

$24

18-month target

The published 18-month target is $24 versus a $18.98 price, which is about 26.4% upside if the Poland trade keeps working.

Financial health

n/a

strength

balance sheet grade n/a — not on this snapshot
risk rank n/a
price stability n/a

health data not available.

Total return vs. market

You invested $10,000 in CEE 3 years ago → it's now worth $21,930.

The index would have given you $13,880.

same period. same starting point. CEE beat the market by $8,050.

source: institutional data · total return

What just happened

missed estimates

There is no quarterly earnings figure provided in the source set, so the only verified profit number is the $0.65 forward EPS estimate.

EPS estimate → expected yearly profit per share → analysts and the primary source both point to $0.65 for fiscal 2029. No quarterly revenue, EPS, or gross margin figures were provided from SEC filings here.

$0.65

eps

n/a

the number that mattered

$0.65 is the only hard earnings anchor in the file, because both the primary source and consensus match on that forward EPS estimate.

as of february 3rd, the closedend fund’s net asset value (nav) was up an eye-catching 20% fiscal year to date.

the fund continues to be the beneficiary of increased foreign investment in poland’s economy and equity market.
in particular, the mega-cap u.s. technology companies have invested in poland and that has resulted in a surge in corporate hiring in the european nation.
as of december 31st, investments in poland accounted for nearly two-thirds of the fund’s holdings.

looking forward, cee’s management team believes that poland’s equity market doesn’t reflect any potential settlement of the russia/ukraine war, leaving room for upside once the market begins to anticipate a resolution. likewise, the fund sees significant possibilities in hungary, as a potential change in that nation’s leadership could unleash eu funds and support equity valuations.
poland’s economy is in the midst of a healthy stretch.
as we went to press, the expectation was that poland’s gdp expanded by 3.6% in 2025, fueled by strong public and private consumption.

source: primary source and wall street consensus, 2026

What could go wrong

the #1 risk is central and eastern Europe equity exposure — this is a region bet first and a stock second.

∘

med

regional drawdown

CEE is built around central and eastern Europe. If the region sells off, there is no separate operating engine here to bail you out.

∘

med

premium valuation

At 40.4x trailing earnings, you are already paying a premium. Premium multiples and small regional funds do not mix well when sentiment turns.

∘

med

institutional sponsorship fading

The latest read shows 7 buyers vs. 12 sellers in 3q2025. That is two straight quarters of net selling, which matters more when the market cap is only about $125M.

∘

med

thin operating visibility

Revenue is n/a and health data is limited in the current snapshot. You can still analyze the fund, but the toolset is different and the margin for false precision is lower.

You are being paid a 2.2% yield to accept a small, country-heavy fund with a risk score of 4.

source: institutional data · regulatory filings · risk analysis

Pay attention to

valuation

40.4x trailing p/e

That multiple is doing a lot of work. If the region keeps working, investors tolerate it. If not, the rerating can be fast.

flow

2 straight quarters of net selling

For a small fund, sponsorship matters. Watch whether the 7 buyers vs. 12 sellers imbalance starts to reverse.

volatility

beta at 1.25

Beta measures market sensitivity. In human-speak: this is not a bunker. It tends to move more than the market.

next catalyst

portfolio disclosures and flow updates

There is no product launch or margin print to watch here. The closest thing to earnings is how the portfolio mix and buyer list change next.

Analyst rankings

coverage depth

thin

This dataset shows long-term target data, but not a deep bench of formal ranking signals. In human-speak: you are not getting a crowded Wall Street consensus here.

3–5 year target midpoint

$24

That implies about 24% upside from $18.98. The market sees room higher, but not enough to ignore the valuation.

3–5 year high target

$30

The stretch case is +60%, or about 14% annualized. That is the optimistic scenario, not the base case.

source: institutional data

Institutional activity

institutions have been net selling for 2 consecutive quarters — 7 buyers vs. 12 sellers in 3q2025. net selling for 2 quarters.

source: institutional data · 1q2025-3q2025

source: institutional data

Price targets

3-5 year target range

$17 $30

$19 current price

$24 target midpoint · +24% from current · 3-5yr high: $30 (+60% · 14% ann'l return)

source: institutional data · analyst targets

The deep dive

CEE

xvary deep dive

cee

the full analysis is in the works.

what you'll get

dcf valuation model

bull / base / bear scenarios

competitive moat breakdown

quarterly earnings tracker

operating model projections

risk matrix with kill criteria

original price target + conviction

updated with every earnings

free · no spam · you'll be first to read it

cee

Get this snapshot in your inbox

Want the deeper analysis?